183 related articles for article (PubMed ID: 1303308)
41. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes.
Reed JC; Yum S; Cuddy MP; Turner BC; Rapp UR
Cell Growth Differ; 1991 May; 2(5):235-43. PubMed ID: 1888699
[TBL] [Abstract][Full Text] [Related]
42. Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/c 3T3 cells. Modulation of EGF-dependent c-myc expression by prostaglandins.
Handler JA; Danilowicz RM; Eling TE
J Biol Chem; 1990 Mar; 265(7):3669-73. PubMed ID: 2105952
[TBL] [Abstract][Full Text] [Related]
43. Epidermal-growth-factor receptors generate Ras.GTP more efficiently than insulin receptors.
Osterop AP; Medema RH; vd Zon GC; Bos JL; Möller W; Maassen JA
Eur J Biochem; 1993 Mar; 212(2):477-82. PubMed ID: 8444185
[TBL] [Abstract][Full Text] [Related]
44. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
O'Banion MK; Levenson RM; Brinckmann UG; Young DA
Mol Endocrinol; 1992 Sep; 6(9):1371-80. PubMed ID: 1331773
[TBL] [Abstract][Full Text] [Related]
45. Consequences of altered oncogene expression in rodent cells.
Pragnell IB; Spandidos DA; Wilkie NM
Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):107-19. PubMed ID: 2866518
[TBL] [Abstract][Full Text] [Related]
46. Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: evidence for multiple autocrine growth factors.
Pironin M; Clément G; Benzakour O; Barritault D; Lawrence D; Vigier P
Int J Cancer; 1992 Jul; 51(6):980-8. PubMed ID: 1639543
[TBL] [Abstract][Full Text] [Related]
47. Transcriptional activation of the c-myc proto-oncogene in murine keratinocytes enhances the response to epidermal growth factor.
Reiss M; Dibble CL; Narayanan R
J Invest Dermatol; 1989 Jul; 93(1):136-41. PubMed ID: 2473136
[TBL] [Abstract][Full Text] [Related]
48. Response of FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene to differentiation induction by N,N-dimethylformamide.
Levine AE; Chakrabarty S
Int J Cancer; 1992 Feb; 50(4):653-8. PubMed ID: 1537633
[TBL] [Abstract][Full Text] [Related]
49. Partial transformation of mouse fibroblastic and epithelial cell lines with the v-myc oncogene.
Falcone G; Summerhayes IC; Paterson H; Marshall CJ; Hall A
Exp Cell Res; 1987 Jan; 168(1):273-84. PubMed ID: 3023119
[TBL] [Abstract][Full Text] [Related]
50. Regulation of surface-differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene.
Basolo F; Serra C; Ciardiello F; Fiore L; Russo J; Campani D; Dolei A; Squartini F; Toniolo A
Int J Cancer; 1992 Jun; 51(4):634-40. PubMed ID: 1601524
[TBL] [Abstract][Full Text] [Related]
51. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
Moscatelli D; Quarto N
J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
[TBL] [Abstract][Full Text] [Related]
52. NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.
Benjamin CW; Connor JA; Tarpley WG; Gorman RR
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4345-9. PubMed ID: 3288991
[TBL] [Abstract][Full Text] [Related]
53. Modified responsiveness of v-Ha-ras-transfected rat fibroblasts to growth factors and a tumor promoter.
Huang M; Kamata N; Nose K; Kuroki T
Mol Carcinog; 1988; 1(2):109-15. PubMed ID: 3076452
[TBL] [Abstract][Full Text] [Related]
54. Fibronectin/laminin and their receptors in aberrant growth control in FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene.
Chakrabarty S; Jan Y; Levine A; McClenic B; Varani J
Int J Cancer; 1989 Aug; 44(2):325-31. PubMed ID: 2527209
[TBL] [Abstract][Full Text] [Related]
55. Activation of ras oncogenes in chemically transformed BALB/MK-2 mouse keratinocytes.
Weissman BE; Arboleda MJ; Kimoto KA; MacDonald MJ; Ochiai R; Der CJ
Mol Carcinog; 1989; 2(3):150-8. PubMed ID: 2506887
[TBL] [Abstract][Full Text] [Related]
56. [Studies on the regulation of glycolipid sulfotransferase activity in human renal cancer cells].
Yabunaka N
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):289-300. PubMed ID: 7774881
[TBL] [Abstract][Full Text] [Related]
57. Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: contrasting effects of oncogenes and heat stress in a murine marrow-derived cell line.
Ahmed N; Berridge MV
Life Sci; 1998; 63(21):1887-903. PubMed ID: 9825767
[TBL] [Abstract][Full Text] [Related]
58. Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells.
Bignami M; Rosa S; Falcone G; Tató F; Katoh F; Yamasaki H
Mol Carcinog; 1988; 1(1):67-75. PubMed ID: 2475135
[TBL] [Abstract][Full Text] [Related]
59. Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
Lito P; Mets BD; Kleff S; O'Reilly S; Maher VM; McCormick JJ
J Biol Chem; 2008 Jan; 283(4):2002-9. PubMed ID: 18048363
[TBL] [Abstract][Full Text] [Related]
60. Dietary protein restriction inhibits growth hormone-induced DNA synthesis without impairing c-myc and c-Ha-ras expression in the liver of hypophysectomized rats.
Triest SK; Thissen JP; Maiter DM; Mauerhoff T; Ketelslegers JM
J Nutr; 1995 Jul; 125(7):1847-53. PubMed ID: 7616300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
